Mesenchymal stem cells (MSCs) have emerged as ideal cell-based therapeutic candidates
for the structural and functional restoration of the diseased kidney. Glial cell line-derived …

Exosomes (Exos) extracted from human adipose mesenchymal stromal/stem cells (hAD-
MSCs) have been reported as therapeutic tools for tissue repair, but how they regulate …

This study aimed to investigate the underlying mechanism of mesenchymal stem cells
(MSCs) on protection of renal ischemia reperfusion injury (IRI). Exosomes originated from …

Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …

New data indicate that abnormal glomerular endothelial cell (GEC)-podocyte crosstalk plays
a critical role in diabetic nephropathy (DN). The aim of our study is to investigate the role of …

Acute kidney injury (AKI) and chronic kidney disease (CKD) are rising in global prevalence
and cause significant morbidity for patients. Current treatments are limited to slowing instead …

Bone marrow-derived mesenchymal stem cells (MSCs) have contributed to the improvement
of diabetic nephropathy (DN); however, the actual mediator of this effect and its role has not …

Acute kidney injury (AKI) is a fatal medical episode caused by sudden kidney damage or
failure, leading to the death of patients within a few hours or days. Previous studies …

Mesenchymal stem/stromal cells (MSCs) have distinct capability for renal repair, but may
have safety concerns. MSC-derived extracellular vesicles emerged as a novel noncellular …

Background Renal fibrosis is a chronic and progressive process affecting kidneys in chronic
kidney disease (CKD). Mesenchymal stem cells-derived exosomes (MSCs-Exo) have been …